Publication | Open Access

ERG–TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin

Tumor BiologyConcurrent Prostatic AdenocarcinomaUrologyGenitourinary CancerPathologyErg–tmprss2 RearrangementProstatic DiseaseMedicineCancer ResearchEndocrine-related CancerUrinary Bladder